Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Inhaled PT005 in COPD
NCT00880490Phase 2Completed
- Sponsor
- Pearl Therapeutics
- Start
- Nov 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of formoterol fumarate MDI in chronic obstructive pulmonary disease (COPD), sponsored by Pearl Therapeutics. Started Nov 2008; status: completed.
02
Drugs
formoterol fumarate MDI
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00880490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00880490.